Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from RELIEF THERAPEUTICS Holding ( (CH:MMTX) ) is now available.
MindMaze Therapeutics and U.S. post-acute care operator Vibra Healthcare reported two-year real-world data from five inpatient rehab facilities showing that MindMaze’s technology-enabled, high-dose neurorehabilitation can materially improve stroke recovery outcomes. Using devices such as MindMotion Go, Izar and MindPod, 210 inpatients received gamified supplemental therapy that increased training time by about 60% per day and was delivered on roughly three-quarters of treatment days.
Compared with matched controls on standard care, stroke patients using the MindMaze platform achieved statistically greater functional gains in mobility and self-care scores, logged around 6.2 hours of extra training per patient and showed higher, clinically meaningful rates of discharge back to the community. The results, presented at the American Society of Neurorehabilitation meeting, suggest the system can raise therapy intensity without adding staff burden, strengthening MindMaze’s positioning as a core tool in neurorehab workflows and offering providers a scalable route to better patient outcomes and faster returns home.
The most recent analyst rating on (CH:MMTX) stock is a Hold with a CHF1.00 price target. To see the full list of analyst forecasts on RELIEF THERAPEUTICS Holding stock, see the CH:MMTX Stock Forecast page.
More about RELIEF THERAPEUTICS Holding
MindMaze Therapeutics, listed on SIX Swiss Exchange, is a Swiss-based provider of scalable, precision neurotherapeutics that combine advanced software, proprietary sensors and AI-driven analytics to support recovery from stroke, Parkinson’s disease and other neurological disorders. Its FDA-cleared and CE-marked digital platforms are designed to plug gaps in specialist clinician capacity and deliver reimbursable, high-dose therapy across hospital, outpatient and home settings.
Average Trading Volume: 385,934
Technical Sentiment Signal: Sell
Current Market Cap: CHF56.74M
For detailed information about MMTX stock, go to TipRanks’ Stock Analysis page.